XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Sep. 30, 2022
Mar. 31, 2022
Assets    
Cash and cash equivalents $ 12,520 $ 14,466
Accounts receivable, net 11,591 11,899
Revenue earned but not billed 1,346 2,421
Inventories, net 16,849 19,832
Prepaid expenses and other current assets 2,493 2,631
Total current assets 44,799 51,249
Property and equipment, net 10,911 11,466
Goodwill 564 350
Other intangible assets, net 2,282 2,404
Deferred tax assets 19,426 17,805
Other long-term assets 3,203 3,543
Total assets 81,185 86,817
Liabilities and Shareholders’ Equity    
Accounts payable 5,938 9,855
Accrued expenses and other 6,263 8,427
Deferred revenue, current 76 76
Current maturities of long-term debt 16 16
Total current liabilities 12,293 18,374
Revolving credit facility 5,000 0
Long-term debt, less current maturities 11 19
Deferred revenue, long-term 526 564
Other long-term liabilities 2,380 2,760
Total liabilities 20,210 21,717
Commitments and contingencies
Shareholders’ equity:    
Preferred stock, $0.01 par value: Shares authorized: 30,000,000 at September 30, 2022 and March 31, 2022; no shares issued and outstanding at September 30, 2022 and March 31, 2022 0 0
Common stock, no par value: Shares authorized: 200,000,000 at September 30, 2022 and March 31, 2022; shares issued: 41,352,020 at September 30, 2022 and 40,570,909 at March 31, 2022; shares outstanding: 31,355,911 at September 30, 2022 and 31,097,872 at March 31, 2022 0 0
Additional paid-in capital 159,460 158,419
Treasury stock, common shares: 9,996,109 at September 30, 2022 and 9,473,037 at March 31, 2022 (36,239) (36,239)
Retained deficit (62,246) (57,080)
Total shareholders’ equity 60,975 65,100
Total liabilities and shareholders’ equity $ 81,185 $ 86,817